ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
ORTX
Delisted
ORTX was delisted on the 23rd of January, 2024.
79 hedge funds and large institutions have $167M invested in Orchard Therapeutics plc American Depositary Shares in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
88% less call options, than puts
Call options by funds: $147K | Put options by funds: $1.25M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
79
Holding in Top 10
–
Calls
$147K
Puts
$1.25M
Top Buyers
| 1 | +$7.52M | |
| 2 | +$2.22M | |
| 3 | +$1.31M | |
| 4 |
Millennium Management
New York
|
+$896K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$862K |
Top Sellers
| 1 | -$7.14M | |
| 2 | -$6M | |
| 3 | -$5.97M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$5.87M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$5.23M |